Fennec Pharmaceuticals

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$9,652
$8,751
$7,925
$6,974
Gross Profit
8,685
8,378
7,256
5,617
EBITDA
-2,533
-782
-909
-4,685
EBIT
-2,558
-808
-934
-4,710
Net Income
-3,152
-1,165
-1,985
-5,735
Net Change In Cash
9,652
8,751
7,925
6,974
Free Cash Flow
-3,686
-4,318
-1,474
-2,206
Cash
18,705
22,676
26,634
40,320
Basic Shares
27,664
27,578
27,460
27,371

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$47,538
$21,252
$1,535
$170
Gross Profit
44,354
19,993
1,449
0
EBITDA
3,600
-12,364
-22,587
-123
EBIT
2,568
-12,651
-22,736
-17,346
Net Income
-436
-16,045
-24,839
-17,456
Net Change In Cash
47,538
21,252
1,535
170
Cost of Revenue
-9,244
Free Cash Flow
26,980
-17,143
-18,058
-14,222
Cash
26,634
13,269
23,774
21,100
Basic Shares
27,294
26,574
26,275
26,006

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$0.11
2025-03-31
-$0.04
2024-12-31
-$0.06